Longevity — Biohacker Baseline
Epitalon + GHK-Cu + NAD+ — cellular-level rejuvenation stack.
Overview
Combines a telomere-associated peptide (Epitalon), a copper-binding matrix peptide (GHK-Cu), and a mitochondrial co-factor (NAD+). Each has published preclinical and early-stage human data on aging-adjacent endpoints: Epitalon for telomerase activation and pineal function, GHK-Cu for skin and soft-tissue regeneration, NAD+ for mitochondrial energy and DNA repair. Non-hormonal, non-suppressive — a baseline protocol for researchers prioritizing healthspan over peak performance.
Who it's for
- 01Researchers 35+ investigating biological-age markers
- 02Recovery-focused protocols (no performance demands)
- 03Researchers new to longevity peptides (start here, not more exotic compounds)
What's inside — 3 compounds
$39.00
View PDP →- Dose
- 10 mg
- Frequency
- Daily
- Weeks
- 1-2
- Category
- peptides
Short high-dose course — 10 mg daily for 10-14 days then stop. Repeat every 6 months.
$49.00
View PDP →- Dose
- 2 mg
- Frequency
- Daily
- Weeks
- 1-12
- Category
- peptides
Subcutaneous preferred. Topical formulations also exist but bioavailability differs.
$123.00
View PDP →- Dose
- 100 mg
- Frequency
- Weekly
- Weeks
- 1-12
- Category
- peptides
Subcutaneous 100 mg/week is the commonly-referenced dose. IV protocols use much higher (500+ mg) but require clinical setting.
Weekly Protocol
Epitalon runs a 14-day loading phase; GHK-Cu and NAD+ run the full 12 weeks. The protocol is intentionally gentle — a maintenance rhythm rather than a peak stack. Repeat 2-3x per year for ongoing effect.
| Compound | Dose | Frequency | Weeks |
|---|---|---|---|
| Epitalon | 10 mg | Daily | 1-2 |
| GHK-Cu | 2 mg | Daily | 1-12 |
| NAD+ 1000mg | 100 mg | Weekly | 1-12 |
Expected Outcomes
- Improved skin quality and elasticity (GHK-Cu mechanism)
- Better sleep and sense of daily energy
- Potential telomere-length biomarker improvement (requires lab testing)
- No hormonal disruption, no PCT required
Safety & Warnings
- NAD+ subcutaneous injection can cause flushing. Administer slowly.
- Epitalon data in humans is limited — most research is preclinical. Treat as investigational.
- Copper overload is theoretically possible with long-term GHK-Cu at high doses. Standard doses appear safe per published data.
Frequently Asked
Will I feel anything?
Subtle. Longevity protocols don't have acute felt effects like testosterone. Changes are measured in months and verified via bloodwork / skin appearance / sleep quality.
Can I add NR or NMN instead of NAD+?
Those are oral precursors, different bioavailability profile. NAD+ subcutaneous is more direct. Oral NMN is a reasonable add-on but not a substitute.
Research disclaimer
All stack suggestions reflect the published literature and are provided for research-reference purposes only. Individual protocols require compound-specific planning. Consult the stacking theory guide before designing your protocol. Not medical advice.